Sector: MedicalEnzon Pharmaceuticals, Inc. (NASDAQ: ENZN)
Headlines
- Enzon Reports Third Quarter 2009 Results
Nov 03, 2009 08:17 AM | ENZN
- Enzon to Release Third Quarter 2009 Earnings on Tuesday, November 3, 2009; Conference Call and Webcast to Follow
Oct 28, 2009 03:00 PM | ENZN
- 15 Breakout Stocks On Huge Volume
Oct 08, 2009 09:51 AM | BRCD, CGR, ENZN, GIII, ICTG, MBRX
- UCB's Cimzia(R), the Only PEGylated Anti-TNF, Approved in Europe
Oct 06, 2009 10:35 AM | ENZN
- PEGINTRON(R) Receives a Recommendation for Approval from FDA Advisory Committee for a New Application in Melanoma
Oct 05, 2009 02:44 PM | ENZN, SGP
- Enzon to Present at Newsmakers in the Biotech Industry Conference
Sep 10, 2009 03:21 PM | ENZN
- Enzon Faces Shareholder Pressure
Feb 10, 2009 10:36 AM | ENZN, GS
- Enzon Pharma Shares Rise on Prospects
Nov 21, 2008 04:38 PM | ENZN, GILD, JNJ, NDAQ, NKTR, PEG
- Analyst Comments: Enzon Pharma, BHP Billiton, Lincoln Electric, Hologic, Ardea Biosciences, Gafisa, Buckeye Partners, Take-Two
Aug 18, 2008 02:55 PM | BBL, BHP, BPL, ENZN, ERTS, GFA
- Periodicals Wrap-Up for Monday, August 11th
Aug 11, 2008 10:28 AM | AAPL, ABB, ACL, ADBE, ADM, AFFY
- Enzon Reports 2nd Quarter 2009 Results
Aug 04, 2009 08:25 AM | ENZN
- CORRECTING and REPLACING Enzon to Present at BMO Focus on Healthcare Conference
Jul 28, 2009 09:34 AM | ENZN
- Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
Jul 27, 2009 01:01 PM | ENZN
- Enzon to Present at BMO Focus on Healthcare Conference
Jul 27, 2009 10:26 AM | ENZN
- DellaCamera Comments on Recent Replacement of Jeffrey H. Buchalter as Chairman of Enzon and Addition of New Independent Director to Enzon’s Board
Jul 23, 2009 04:46 PM | ENZN
- Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director
Jul 23, 2009 04:34 PM | ENZN
- DellaCamera Advised That Enzon Has Set July 24, 2009 as Record Date for Consent Solicitation
Jul 21, 2009 04:09 PM | ENZN
- DellaCamera Makes Formal Request for Enzon to Set Record Date for Consent Solicitation
Jul 07, 2009 12:07 PM | ENZN
- Enzon Commences Phase II Trial of PEG-SN38
Jun 22, 2009 04:01 PM | ENZN
- DellaCamera Reports on Town Hall Meeting for Enzon Shareholders and Provides Update on Consent Solicitation Process
Jun 17, 2009 10:05 AM | ENZN
- Form 4 HORAK IVAN D For: Sep 02 (10K)
Sep 04, 2009 09:00 PM
- Form 3 ENZON PHARMACEUTICALS For: Jul 23 Filed by: IRIDIAN ASSET MANAGEMENT LLC/CT (10K)
Jul 31, 2009 06:00 PM
- Form 3 Levy Harold J For: Jul 23 (10K)
Jul 31, 2009 06:00 PM
- Form 4 Denner Alexander J For: May 21 (10K)
May 26, 2009 06:52 PM
- Form 3 Denner Alexander J For: May 21 (10K)
May 26, 2009 06:49 PM
- Form 4 Mulligan Richard For: May 21 (10K)
May 26, 2009 05:34 PM
- Form 4 TOOMAN CRAIG A For: Apr 03 (10K)
Apr 07, 2009 05:16 PM
- Form 4 del Campo Ralph For: Apr 03 (10K)
Apr 07, 2009 05:15 PM
- Form 4 Davit Paul Stephen For: Apr 03 (10K)
Apr 07, 2009 05:13 PM
- Form 4 HORAK IVAN D For: Apr 03 (10K)
Apr 07, 2009 05:09 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
ENZN
|
Compare to S&P
|
| YTD |
43.91 %
|
25.45 %
|
| 4 Weeks |
2.32 %
|
1.23 %
|
| 12 Weeks |
4.74 %
|
2.15 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -375.00 %
|
|
EPS Growth in Last Year: -1,000.00 %
|
|
Sales Growth in Last Quarter: -2.97 %
|
|
Sales Growth in Last Quarter: -7.40 %
|
|
